» Articles » PMID: 33255540

The EuRRECa Project As a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical Outcomes

Abstract

Rare disease (RD) registries are important platforms that facilitate communication between health care professionals, patients and other members of the multidisciplinary team. RD registries enable data sharing and promotion of research and audits, often in an international setting, with the overall aim of improving patient care. RD registries also have a fundamental role in supporting the work of clinical networks such as the European Reference Networks (ERNs) for rare diseases. With the recent expansion of RD registries, it has become even more essential to outline standards of good practice in relation to governance, infrastructure, documentation, training, audits and adopting the Findable, Accessible, Interoperable and Reusable (FAIR) data principles to maintain registries of high quality. For the purpose of this paper, we highlight vital aspects of data access and data governance policies for RD registries, using the European Registries for Rare Endocrine Conditions (EuRRECa) as an example of a project that aims to promote good standards of practice for improving the quality of utilization of RD registries.

Citing Articles

Data collection on rare bone and mineral conditions in Europe: The landscape of registries and databases.

Priego Zurita A, Grasemann C, Boarini M, Chapurlat R, Mordenti M, Javaid M Eur J Med Genet. 2024; 66(12):104868.

PMID: 38832910 PMC: 11035979. DOI: 10.1016/j.ejmg.2023.104868.


Scoping review of the recommendations and guidance for improving the quality of rare disease registries.

Tarride J, Okoh A, Aryal K, Prada C, Milinkovic D, Keepanasseril A Orphanet J Rare Dis. 2024; 19(1):187.

PMID: 38711103 PMC: 11075280. DOI: 10.1186/s13023-024-03193-y.


Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol.

Clement S, Visser W, Lebbink C, Albano D, Claahsen-van der Grinten H, Czarniecka A Endocr Connect. 2023; 12(3).

PMID: 37931414 PMC: 9986407. DOI: 10.1530/EC-22-0306.


A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance.

Hageman I, van Rooij I, de Blaauw I, Trajanovska M, King S Orphanet J Rare Dis. 2023; 18(1):106.

PMID: 37147718 PMC: 10163740. DOI: 10.1186/s13023-023-02719-0.


Attitudes Toward Personal Health Data Sharing Among People Living With Sickle Cell Disorder, Exemplar for Study of Rare Disease Populations.

Baines R, Stevens S, Garba-Sani Z, Chatterjee A, Austin D, Leigh S J Patient Cent Res Rev. 2023; 10(2):68-76.

PMID: 37091117 PMC: 10117534. DOI: 10.17294/2330-0698.2006.


References
1.
Brasil S, Pascoal C, Francisco R, Dos Reis Ferreira V, Videira P, Valadao A . Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?. Genes (Basel). 2019; 10(12). PMC: 6947640. DOI: 10.3390/genes10120978. View

2.
Ali S, Bryce J, Cools M, Korbonits M, Beun J, Taruscio D . The current landscape of European registries for rare endocrine conditions. Eur J Endocrinol. 2018; 180(1):89-98. PMC: 6347278. DOI: 10.1530/EJE-18-0861. View

3.
Kodra Y, Weinbach J, Posada-de-la-Paz M, Coi A, Lemonnier S, van Enckevort D . Recommendations for Improving the Quality of Rare Disease Registries. Int J Environ Res Public Health. 2018; 15(8). PMC: 6121483. DOI: 10.3390/ijerph15081644. View

4.
Cheah P, Piasecki J . Data Access Committees. BMC Med Ethics. 2020; 21(1):12. PMC: 6998828. DOI: 10.1186/s12910-020-0453-z. View

5.
Coi A, Santoro M, Villaverde-Hueso A, Lipucci di Paola M, Gainotti S, Taruscio D . The Quality of Rare Disease Registries: Evaluation and Characterization. Public Health Genomics. 2016; 19(2):108-15. DOI: 10.1159/000444476. View